Population-based impact of routine infant immunization with pneumococcal conjugate vaccine in the USA.

Grijalva CG, Griffin MR
Expert Rev Vaccines. 2008 7 (1): 83-95

PMID: 18251696 · DOI:10.1586/14760584.7.1.83

In the year 2000, a heptavalent pneumococcal conjugate vaccine (PCV7) was licensed and recommended for routine immunization of infants in the USA. During the following years, a number of studies documented the impact of this immunization program on rates of invasive pneumococcal disease, pneumonia and otitis media. This article aims to summarize current evidence on the population-based impact of this infant immunization program in the USA.

MeSH Terms (7)

Humans Infant Otitis Media Pneumococcal Infections Pneumococcal Vaccines Pneumonia United States

Connections (1)

This publication is referenced by other Labnodes entities:

Links